[
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For February",
    "summary": "IXJ: Healthcare Sector Dashboard For February",
    "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771408800,
      "headline": "IXJ: Healthcare Sector Dashboard For February",
      "id": 139136343,
      "image": "",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7"
    }
  },
  {
    "ts": null,
    "headline": "Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $432",
    "summary": "Piper Sandler  analyst David Amsellem   maintains Amgen (NASDAQ:AMGN) with a Overweight and raises the price target from $381 to $432.",
    "url": "https://finnhub.io/api/news?id=a1f89ce40d93cb7d15869733d9a6acd83c7e5143274d7d160a16ddb4b54527f1",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771403253,
      "headline": "Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $432",
      "id": 139134643,
      "image": "",
      "related": "AMGN",
      "source": "Benzinga",
      "summary": "Piper Sandler  analyst David Amsellem   maintains Amgen (NASDAQ:AMGN) with a Overweight and raises the price target from $381 to $432.",
      "url": "https://finnhub.io/api/news?id=a1f89ce40d93cb7d15869733d9a6acd83c7e5143274d7d160a16ddb4b54527f1"
    }
  }
]